Showing 15,601 - 15,620 results of 15,769 for search '"immunosuppression"', query time: 0.17s Refine Results
  1. 15601

    GBS hyaluronidase mediates immune suppression in a TLR2/4- and IL-10-dependent manner during pregnancy-associated infection by Michelle Coleman, Austyn Orvis, Alyssa Brokaw, Anna Furuta, Kavita Sharma, Phoenicia Quach, Avneet Bhullar, Rhea Sanghavi, Shayla Nguyen, Erin Sweeney, Ravin Seepersaud, Blair Armistead, Kristina M. Adams Waldorf, Lakshmi Rajagopal

    Published 2023-10-01
    “…GBS secretes a hyaluronidase enzyme that is thought to digest host hyaluronan into immunosuppressive disaccharides that dampen TLR2/4 signaling, leading to increased bacterial dissemination and adverse outcomes. …”
    Get full text
    Article
  2. 15602

    Graft Failure Due to Nonadherence among 150 Prospectively-Followed Kidney Transplant Recipients at 18 Years Post-transplant: Our Results and Review of the Literature by Jeffrey J. Gaynor, Giselle Guerra, David Roth, Linda Chen, Warren Kupin, Adela Mattiazzi, Mariella Ortigosa-Goggins, Marina M. Tabbara, Lissett Moni, George W. Burke, Gaetano Ciancio

    Published 2022-02-01
    “…Methods: Determination of the patient becoming NA in taking his/her immunosuppressive medications, and the underlying cause of graft loss, were determined prospectively by the attending physicians. …”
    Get full text
    Article
  3. 15603

    Comparison of clinical features and outcomes of proliferative, fibrotic, and mixed subtypes of IgG4-related disease: A retrospective cohort study by Linyi Peng, Xinlu Zhang, Jiaxin Zhou, Jieqiong Li, Zheng Liu, Hui Lu, Yu Peng, Yunyun Fei, Yan Zhao, Xiaofeng Zeng, Wen Zhang, Lishao Guo

    Published 2024-02-01
    “…We then assessed the differences in treatment outcomes among 448 patients receiving glucocorticoids alone or in combination with immunosuppressants. Moreover, risk factors of relapse were revealed by applying the univariate and multivariate Cox regression analysis. …”
    Get full text
    Article
  4. 15604
  5. 15605

    MZF1 promotes tumour progression and resistance to anti-PD-L1 antibody treatment in hepatocellular carcinoma by Anna Kan, Shuang Liu, Minke He, Dongsheng Wen, Haijing Deng, Lichang Huang, Zhicheng Lai, Yexing Huang, Ming Shi

    Published 2024-01-01
    “…Results: Single-cell RNA-sequencing suggested an immunosuppressive environment and a strong correlation with the immune checkpoint programmed death ligand 1 (PD-L1) in MZF1-overexpressing tumours. …”
    Get full text
    Article
  6. 15606
  7. 15607

    Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate by Ken Liu, Ken Liu, Ken Liu, Jinbiao Chen, Yang Zhao, Jade Boland, Ka Ka Ting, Glen Lockwood, Catriona McKenzie, James Kench, Mathew A. Vadas, Mathew A. Vadas, Jennifer R. Gamble, Jennifer R. Gamble, Geoffrey W. McCaughan, Geoffrey W. McCaughan, Geoffrey W. McCaughan

    Published 2023-09-01
    “…IntroductionLiver cancers exhibit abnormal (leaky) vasculature, hypoxia and an immunosuppressive microenvironment. Normalization of tumor vasculature is an emerging approach to treat many cancers. …”
    Get full text
    Article
  8. 15608

    Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study by Myrto Nikoloudaki, Myrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, Irini Flouri, Irini Flouri, Noemin Kapsala, Argyro Repa, Argyro Repa, Pelagia Katsimbri, Evangelos Theotikos, Sofia Pitsigavdaki, Sofia Pitsigavdaki, Katerina Pateromichelaki, Katerina Pateromichelaki, Antonios Bertsias, Antonios Bertsias, Antonia Elezoglou, Prodromos Sidiropoulos, Prodromos Sidiropoulos, Prodromos Sidiropoulos, Antonis Fanouriakis, Antonis Fanouriakis, Dimitrios Boumpas, Dimitrios Boumpas, George Bertsias, George Bertsias, George Bertsias

    Published 2023-01-01
    “…ObjectiveTo obtain real-world data on outcomes of belimumab treatment and respective prognostic factors in patients with systemic lupus erythematosus (SLE).MethodsObservational study of 188 active SLE patients (median disease duration 6.2 years, two previous immunosuppressive/biological agents) treated with belimumab, who were monitored for SLEDAI-2K, Physician Global Assessment (PGA), LLDAS (lupus low disease activity state), remission (DORIS/Padua definitions), SELENA-SLEDAI Flare Index, SLICC/ACR damage index and treatment discontinuations. …”
    Get full text
    Article
  9. 15609

    Biological activity reduction and mitochondrial and lysosomal dysfunction of mesenchymal stem cells aging in vitro by Ge Zhang, Yuli Wang, Jianhua Lin, Bo Wang, Ali Mohsin, Zhimin Cheng, Weijie Hao, Wei-Qiang Gao, Huiming Xu, Meijin Guo

    Published 2022-08-01
    “…Methods First, we examined cell activities, including proliferation and immigration ability, differentiation potential, and immunosuppressive capacity of UMSCs at an early and late passages as P4 (named UMSC-P4) and P9 (named UMSC-P9), respectively. …”
    Get full text
    Article
  10. 15610

    Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system by Francesca Filippi-Arriaga, Cristina Aguilera, Cristina Aguilera, Cristina Aguilera, Elena Guillén, Elena Guillén, Lucía Bellas, Eulàlia Pérez, Lourdes Vendrell, Antònia Agustí, Antònia Agustí, Antònia Agustí, Gloria Cereza, Gloria Cereza

    Published 2023-07-01
    “…Vaccines such as covid-19 and pneumococcus (68, 21.3%), antineoplastics such as paclitaxel, trastuzumab and vincristine (39, 12.2%) and immunosuppressants such as methotrexate and tocilizumab (35, 11%) were the most frequent drug subgroups involved. …”
    Get full text
    Article
  11. 15611
  12. 15612
  13. 15613
  14. 15614

    BLEEDING, FVIII ACTIVITY, AND SAFETY 3 YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC: RESULTS FROM GENER8-1 by MC Ozelo, J Mahlangu, B Madan, J Mason, F Peyvandi, AV Drygalski, G Yamaguti-Hayakawa, TM Robinson, SW Pipe, TT Gener-Eigh

    Published 2023-10-01
    “…Since the previous data cut, 34/134 participants (25.4%) had alanine aminotransferase (ALT) elevation, mostly Grade 1, but none initiated immunosuppressants. Overall, 106/134 (79.1%) used corticosteroids for ALT elevation for median 33 weeks. …”
    Get full text
    Article
  15. 15615

    Brevundimonas vesicularis SEPTICAEMIA IN A KID WITH CONGENITAL GOITRE by Mitja Gombač, Igor Gruntar, Pavel Kvapil, Tanja Švara

    Published 2016-10-01
    “…To date, B. vesicularis has been isolated from water, soil, plants and several human clinical specimens, mostly in immunosuppressed patients causing endocarditis, arthritis, keratitis and septicaemia. …”
    Get full text
    Article
  16. 15616

    A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery by Mahdi Abdoli Shadbad, Sahar Safaei, Oronzo Brunetti, Afshin Derakhshani, Parisa Lotfinejad, Ahad Mokhtarzadeh, Nima Hemmat, Vito Racanelli, Antonio Giovanni Solimando, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran

    Published 2021-08-01
    “…Based on the current evidence, the restoration of miR-424-5p, miR-138-5p, miR-570-3p, miR-200c-3p, miR-383-5p, miR-34a-5p, miR-3609, miR-195-5p, and miR-497-5p can inhibit tumoral PD-L1 expression, transform immunosuppressive tumor microenvironment into the pro-inflammatory tumor microenvironment, inhibit tumor proliferation, suppress tumor migration, enhance chemosensitivity of tumoral cells, stimulate tumor apoptosis, arrest cell cycle, repress the clonogenicity of tumoral cells, and regulate various oncogenic signaling pathways in TNBC cells. …”
    Get full text
    Article
  17. 15617

    Linear growth and bone metabolism in pediatric patients with inflammatory bowel disease by Paloma Velez de Andrade Lima Simões Ferreira, André de Souza Cavalcanti, Giselia Alves Pontes da Silva

    Published 2019-03-01
    “…Conclusion: Insufficient growth and low bone mineral density in pediatric patients with inflammatory bowel disease are complex problems that result from multiple factors including chronic inflammation, malnutrition, decreased physical activity, late puberty, genetic susceptibility, and immunosuppressive therapies, such as glucocorticoids. Resumo: Objetivo: Revisar a fisiopatologia e os métodos de avaliação do crescimento linear e densidade mineral óssea em crianças e adolescentes com diagnóstico de doença inflamatória intestinal. …”
    Get full text
    Article
  18. 15618

    The Molecular Quality and Mitochondrial Activity of Porcine Cumulus–Oocyte Complexes Are Affected by Their Exposure to Three Endocrine-Active Compounds under 3D In Vitro Maturation... by Gabriela Gorczyca, Kamil Wartalski, Marek Romek, Marcin Samiec, Małgorzata Duda

    Published 2022-04-01
    “…For those reasons, this study sought to examine whether selected EACs, which encompass the fungicide vinclozolin (Vnz), the androgenic anabolic steroid nandrolone (Ndn) and the immunosuppressant cyclosporin A (CsA), affect the developmental competence and molecular quality (MQ) of porcine cumulus–oocyte complexes (COCs) subjected to in vitro maturation (IVM) under 3D culture conditions. …”
    Get full text
    Article
  19. 15619

    Incidence and risk factors for cancer in people with type 1 diabetes, stratified by stages of diabetic kidney disease: a nationwide Finnish cohort studyResearch in context by Maija Feodoroff, Valma Harjutsalo, Sari Mäkimattila, Per-Henrik Groop

    Published 2024-05-01
    “…In addition, individuals with a kidney transplant/transplantation (KT) have markedly increased cancer risk due to chronic use of immunosuppressive agents. However, it has not been elucidated whether the observed excess cancer risk is related to KT or whether diabetic kidney disease (DKD) per se is a risk factor for cancer in individuals with T1D. …”
    Get full text
    Article
  20. 15620

    Differential regulatory T cell signature after recovery from mild COVID-19 by Pedro Henrique de Sousa Palmeira, Rephany Fonseca Peixoto, Bárbara Guimarães Csordas, Isac Almeida de Medeiros, Fátima de Lourdes Assunção Araújo de Azevedo, Robson Cavalcante Veras, Daniele Idalino Janebro, Ian P.G. Amaral, Tatjana Souza Lima Keesen

    Published 2023-03-01
    “…Collectively, our study suggests that changes in the immunosuppressive repertoire of Tregs can influence the development of a distinct COVID-19 clinical profile, revealing that a possible modulation of Tregs exists among volunteers of the Mild Recovered group between those who did and did not develop certain symptoms, leading to mild disease.…”
    Get full text
    Article